Skip to main content
OpenTrials

Clinical trial condition

Proteostasis Deficiencies

Explore clinical trials studying Proteostasis Deficiencies. Study availability and eligibility vary by location and protocol.

1,350 public trials 353 recruiting studies
Refine in advanced search Browse all conditions

Proteostasis Deficiencies trial results

Completed

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

NCT00666211

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +108 more
Locations
  • Jennie Stuart Medical Center Hopkinsville, Kentucky, United States
  • Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States
  • Erlanger Health System Chattanooga, Tennessee, United States
  • Tennessee Plateau Oncology Crossville, Tennessee, United States
View Trial Details
Completed

Open-Label Phase 1/2 Study of VELCADE for Injection in Patients With Light-chain (AL)-Amyloidosis

NCT00298766

Conditions
Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • Winship Cancer Center - Emory Clinic School of Medicine Atlanta, Georgia, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • MSKCC New York, United States
View Trial Details
Completed

Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT00403104

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • L. Boltzmann Forschungsinstitut, Neurologische Abteilung, Kaiser Franz Josef Hospital, Wien Vienna, Austria
  • UCL Saint-Luc Brussels, Belgium
  • UZ Leuven Leuven, Belgium
  • Hopital Roger Salengro - Clinique Neurologique, Neurologie A Lille, France
View all 26 locations
View Trial Details
Completed

A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)

NCT00694941

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
Locations
  • Prof. Maloteaux, UCL Saint-Luc Brussels, Belgium
  • Prof. Wim Robberecht, UZ Leuven Leuven, Belgium
  • Prof. Alain Destee, Hopital Roger Salengro - Clinique Neurologique, Neurologie A Lille, France
  • Prof. Philippe Couratier, Hopital Duruytren Limoges, France
View all 25 locations
View Trial Details

Related conditions